Your Location：
Home >
Browse articles >
Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis
ReviewPaper | Updated：2021-09-24
|

    • Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis

    • Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis

    • 中国结合医学杂志（英文版）   页码：1-7

    Scan for full text

  • Zhao-ying Liang, Cai-wen Qian, Tao-hua Lan, 等. Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis[J/OL]. 1-7. DOI：

    Zhao-ying Liang, Cai-wen Qian, Tao-hua Lan, et al. Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis[J/OL]. 1-7. DOI：

  •  
  •  
FULL TEXT LINK
More>

0

浏览量

0

Downloads

0

CSCD

文章被引用时，请邮件提醒。
Submit
工具集
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Schisandrin B Protects against Ischemic Brain Damage by Regulating PI3K/AKT Signaling in Rats
Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κ B-ROS/NLRP3 Pathway

相关作者

暂无数据

相关机构

Department of Neurology, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian Province, China;Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China
Department of Pharmacology, Southwest Medical University, Luzhou, Sichuan Province, China;Sichuan Institute for Translational Chinese Medicine, Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China;Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, College of Pharmacy, Changsha Medical University, Changsha, China;Sichuan Fengchun Pharmaceutical Co., Ltd., Deyang, Sichuan Province, China;Sichuan Ant Recommendation Biotechnology Co., Ltd., Chengdu, China
0